ABT 724 trihydrochloride

Discontinued Product

2214 has been discontinued.

View all D<sub>4</sub> Receptors products.
Description: Potent and selective D4 partial agonist; proerectile
Chemical Name: 2-[[4-(2-Pyridinyl)-1-piperazinyl]methyl]-1H-benzimidazole trihydrochloride
Purity: ≥99% (HPLC)
Datasheet
Citations
Reviews
Literature (3)

Biological Activity for ABT 724 trihydrochloride

ABT 724 trihydrochloride is an ABT 724 is a potent dopamine D4 receptor partial agonist (EC50 = 12.4 nM; 61% efficacy vs. dopamine), which displays no agonist activity at D2 receptors (EC50 > 10 μM). ABT 724 is selective in rats in vivo and produces penile erection following i.c.v. administration, and increases intracavernosal pressure and potentiates the proerectile effects of sildenafil following s.c. administration. This compound displays minimal side effects.

External Portal information for ABT 724 trihydrochloride

The Chemical Probes webpages of the Structural Genomics Consortium are a portal that offers independent guidance on the selection and/or application of small molecules for research. The use of ABT 724 is reviewed on the chemical probes website.

Technical Data for ABT 724 trihydrochloride

M. Wt 402.75
Formula C17H19N5.3HCl
Storage Desiccate at +4°C
Purity ≥99% (HPLC)
CAS Number 587870-77-7
PubChem ID 16759165
InChI Key AZFUVPBLKQGSRI-UHFFFAOYSA-N
Smiles Cl.Cl.Cl.C(N1CCN(CC1)C1=NC=CC=C1)C1=NC2=CC=CC=C2N1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for ABT 724 trihydrochloride

References for ABT 724 trihydrochloride

References are publications that support the biological activity of the product.

Stewart et al (2004) DA D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning. J.Med.Chem. 47 2348 PMID: 15084133

Cowart et al (2004) Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a DArgic agent with a novel mode of action for the potential treatment of erectile dysfunction. J.Med.Chem. 47 3853 PMID: 15239663

Brioni et al (2004) Activation of DA D4 receptors by ABT-724 induces penile erection in rats. Proc.Natl.Acad.Sci.USA 101 6758

View Related Products by Target

View Related Products by Product Action

View all D4 Receptor Agonists

Keywords: ABT 724 trihydrochloride, ABT 724 trihydrochloride supplier, Potent, selective, D4, partial, agonists, proerectile, Dopamine, Receptors, dopaminergic, ABT724, trihydrochloride, 2214, Tocris Bioscience

Citations for ABT 724 trihydrochloride

Citations are publications that use Tocris products.

Currently there are no citations for ABT 724 trihydrochloride.

Reviews for ABT 724 trihydrochloride

There are currently no reviews for this product. Be the first to review ABT 724 trihydrochloride and earn rewards!

Have you used ABT 724 trihydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Dopamine Receptors Scientific Review

Dopamine Receptors Scientific Review

Written by Phillip Strange and revised by Kim Neve in 2013, this review summarizes the history of the dopamine receptors and provides an overview of individual receptor subtype properties, their distribution and identifies ligands which act at each receptor subtype. Compounds available from Tocris are listed.

Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.